- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06234293
Near-Infrared Light Devices Versus Landmark Approach for Peripheral Venous Access in Intensive Care Unit (NINTENDO)
Near-Infrared Light Devices Versus Landmark Approach for Peripheral Venous Access in Intensive Care Unit: A Randomized Controlled Study
The central venous catheter (CVC) is commonly used in intensive care unit (ICU). The primary complications associated with CVCs especially with prolonged use include thrombosis and infections. Hence, it is essential to remove the CVC as soon as it becomes unnecessary.
Peripheral intravenous cannulation (PIVC) on a critically ill patient can be a significant challenge for nurses. After several days in ICU, patients may develop significant edema in the upper limbs, complicating the PIVC.
Near-infrared light devices (NILD) are medical devices that use near-infrared light to highlight the patient's peripheral venous network directly on their skin. The advantage of this device is its minimal training and ease of use for effective application. Nurses can use this medical device without specific conditions once they have received training on its use. The vein illuminator has not been extensively studied in ICU.
This study aims to compare two techniques for PIVC in critically ill patients with existing CVC for whom maintaining the deep venous access is no longer indicated.
The investigators hypothesize that the use of the NILD would increase the success rate of first-attempt PIVC insertion compared to a landmark approach (traditional method) for PIVC in ICU.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a multicenter randomized controlled study. 380 patients will be randomly assigned with a 1:1 ratio to landmark approach (standard group) or near-infrared light device (interventional group).
Randomization will be done immediately after the enrollment of the patient. Randomization will be stratified by center and according to anticipated difficult venous access defined by:
- BMI > 30 Kg/m2
- Increase in body weight between admission and day of inclusion > 10%.
- Clinically evident edema of the upper limbs (with pitting)
- Absence of visible or palpable veins on arms and forearms If one or more items are present, the patient is classified as difficult to venous access.
Once the patient has been enrolled and randomized, the nurse in charge of the patient performs the PIVC according to the randomization group as soon as possible after randomization.
The nurse will have a maximum of 3 attempts before handing over to another nurse. The total number of attempts will be 5 with the allocated method (traditional method or NILD).
In the case of failure after 5 initial attempts, the intervention will be considered as a failure. However, a maximum of 5 additional attempts will be allowed with any method on the day of randomization. The success or failure of PIVC will be recorded, as well as the device used. The attempts should be performed within 6 hours after randomization.
If one of the 5 first initial attempts is successful, the study continues until the PIVC is removed (max 7 days according to recommendations) or patient discharge, whichever comes first, in order to evaluate the occurrence of local complications.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Aude FERRIER
- Phone Number: +33238744077
- Email: aude.ferrier@chu-orleans.fr
Study Locations
-
-
-
Chartres, France
- Recruiting
- CH de Chartres
-
Contact:
- Gaetan BADRE
-
Le Mans, France
- Recruiting
- CH Le Mans
-
Contact:
- Aurélie BRASSELET
-
Orléans, France
- Recruiting
- CHU Orleans
-
Contact:
- Aude FERRIER
-
Tours, France
- Not yet recruiting
- CHU de Tours
-
Contact:
- DESPRES Amélie
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- ≥18 years old
- Hospitalized in ICU
- with a deep venous catheter (jugular, subclavian or femoral)
- In whom the use of a deep venous line is no longer justified (absence of: vasopressor amines, chemotherapy, parenteral nutrition, hypertonic solutions)
Exclusion Criteria:
- Absolute contraindication or anatomical impossibility to perform a PIVC on the upper limbs
- Patient already included in the study
- Tattoo covering most of both forearms
- Adult subject to a legal protection measure (guardianship, curators, person under court protection)
- Persons deprived of their liberty by a judicial or administrative decision, persons hospitalised without consent and persons admitted to a health or social establishment for purposes other than research.
- Pregnant or breast-feeding woman
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: near-infrared light device
the device used is the AccuVein AV500® (Accuvein, New York USA).
Nurses will have to find the vein for the PIVC using the near-infrared light device.
Nurses will have to proceed as follows: apply the tourniquet, put on the near infrared light onto the upper limb.
PIVC on the lower limbs is forbidden in this study.
The recommended projection distance is around 20 cm, however, the optimal distance of projection can vary between 10 and 45 cm.
After finding the vein, Nurses proceed to PIVC with the device turned on, the peripheral venous network visible on the skin of the patient.
After the cannulation and to confirm the functionality of the peripheral intravenous access a flash of 10cc of an isotonic solution (NaCl 0.9%) will be injected
|
Nurses will have to find the vein for the PIVC using the near-infrared light device.
|
No Intervention: landmark approach
PIVC will be done by a nurse on an upper limb according to the standard approach.
The nurse will proceed as follows: apply the tourniquet and find a vein for the catheterization, standard techniques to highlight veins can be used (apply alcohol, tap veins …).
After finding a vein, the nurses proceed to the PIVC according to his / her habits.
The use of any device is forbidden.
After the cannulation and to confirm the functionality of the peripheral venous access a flash of 10cc of an isotonic solution (NaCl 0.9%) will be injected.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Success rate on the first attempt of PIVC in ICU using NILD
Time Frame: Baseline
|
To show that the use of the NILD improves the success rate on the first attempt of PIVC in ICU for patients for whom the use of a deep venous catheter is no longer justified. The success of PIVC will be determined by the presence of venous return during catheterization in the reflux chamber, the full catheter introduction, and the administration of a 10cc syringe of isotonic solution (NaCl 0.9%) with a flash without extravasation. A puncture attempt is defined by the effraction of the skin barrier by the device. During a puncture, repositioning/change of catheter direction is permitted. Peripheral intravenous puncture will be performed by nurses only. |
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
number of attempts before successful PIVC
Time Frame: Baseline
|
Compare the number of attempts before successful PIVC between the traditional method (standard group) and the use of NILD (interventional group). The number of puncture attempts will be defined by the number of attempts between inclusion and successful of PIVC (last attempt included). On the day of inclusion in the study, each nurse has a maximum of three attempts at PIVC, per patient, depending on the randomization arm. The maximum number of initial attempts per patient is 5. |
Baseline
|
occurrence of local complications
Time Frame: Day 7
|
Compare the occurrence of local complications (phlebitis, extravasation) between the two groups in patients for whom PIVC is considered successful. - The occurrence and type of local complications within 7 days of successful PIVC will be compared between the two groups, as well as their time of occurrence after placement (until removal of the medical device or until discharge from the hospital department). if the patient is discharged before 7 days). The main local complications are venous inflammation and extravasation. Local signs to watch out for include pain, swelling and induration. The presence of any of these signs during daily monitoring will lead to its withdrawal. Only medical confirmation of venous inflammation and extravasation will be recorded for this study. |
Day 7
|
success rate of PIVC according to nurses's experience
Time Frame: Baseline
|
Compare the success rate of PIVC according to nurses' experience between the two groups. The success rate or PIVC according to nurses-experience between the two groups will be compared by stratification: nurses with less than one year's nursing experience, between 1 to 5 years' experience and more than 5 years. |
Baseline
|
success rate of PIVC in patients considered with anticipated difficult intravenous access
Time Frame: Baseline
|
Compare the success rate of PIVC in patients considered with anticipated difficult intravenous access between the two groups. - Anticipated difficult PIVC will be defined as follows:
|
Baseline
|
PIVC insertion time
Time Frame: Baseline
|
Compare PIVC insertion time between the two groups
|
Baseline
|
pain levels
Time Frame: Baseline
|
Compare pain levels in conscious patients between the two groups using the pain verbal analog scale from 0 to 10, where 0 is no pain and 10 unbearable pain.
|
Baseline
|
Collaborators and Investigators
Investigators
- Principal Investigator: Aude FERRIER, CHU Orleans
Publications and helpful links
General Publications
- Gregg SC, Murthi SB, Sisley AC, Stein DM, Scalea TM. Ultrasound-guided peripheral intravenous access in the intensive care unit. J Crit Care. 2010 Sep;25(3):514-9. doi: 10.1016/j.jcrc.2009.09.003. Epub 2009 Oct 15.
- Park JM, Kim MJ, Yim HW, Lee WC, Jeong H, Kim NJ. Utility of near-infrared light devices for pediatric peripheral intravenous cannulation: a systematic review and meta-analysis. Eur J Pediatr. 2016 Dec;175(12):1975-1988. doi: 10.1007/s00431-016-2796-5. Epub 2016 Oct 26.
- Carr PJ, Rippey JCR, Cooke ML, Trevenen ML, Higgins NS, Foale AS, Rickard CM. Factors associated with peripheral intravenous cannulation first-time insertion success in the emergency department. A multicentre prospective cohort analysis of patient, clinician and product characteristics. BMJ Open. 2019 Apr 2;9(4):e022278. doi: 10.1136/bmjopen-2018-022278.
- Bridey C, Thilly N, Lefevre T, Maire-Richard A, Morel M, Levy B, Girerd N, Kimmoun A. Ultrasound-guided versus landmark approach for peripheral intravenous access by critical care nurses: a randomised controlled study. BMJ Open. 2018 Jun 9;8(6):e020220. doi: 10.1136/bmjopen-2017-020220.
- Curtis SJ, Craig WR, Logue E, Vandermeer B, Hanson A, Klassen T. Ultrasound or near-infrared vascular imaging to guide peripheral intravenous catheterization in children: a pragmatic randomized controlled trial. CMAJ. 2015 May 19;187(8):563-570. doi: 10.1503/cmaj.141012. Epub 2015 Apr 20.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHRO-2022-14
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Illness
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedNeonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Yale UniversityNational Institute on Aging (NIA)RecruitingCritical Illness | Illness, CriticalUnited States
-
McMaster UniversityLondon Health Sciences Centre; McMaster Children's Hospital; Canadian Critical...CompletedPediatric Critical IllnessCanada
-
Boston Children's HospitalCompleted
-
St Helens & Knowsley Teaching Hospitals NHS TrustManchester University NHS Foundation TrustCompleted
-
Sándor BeniczkyUniversity of Aarhus; Danish Council for Independent Research; Søster og Verner...CompletedCritical Illness Myopathy | Myopathy Critical IllnessDenmark
-
Hospital de Clinicas de Porto AlegreUnknownCritical Illness PolyneuropathiesBrazil
-
Peking Union Medical College HospitalBaxter Healthcare CorporationUnknownNutrition Therapy for Critical Illness
-
Assistance Publique - Hôpitaux de ParisRecruitingCritical Illness Related Corticosteroids InsufficiencyFrance
-
Yuzuncu Yıl UniversityKahramanmaras Sutcu Imam University; Izmir Ataturk Training and Research HospitalCompleted
Clinical Trials on near-infrared light device
-
China Medical University HospitalNot yet recruiting
-
University of MiamiOffice of Naval Research (ONR)Completed
-
University College, LondonMoorfields Eye Hospital NHS Foundation TrustRecruiting
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Medical College of WisconsinThe New York Eye & Ear InfirmaryCompletedDiabetic Macular EdemaUnited States
-
Cerehealth Corp.Colorado Neurological Institute; Tug McGraw FoundationCompletedTBI (Traumatic Brain Injury)
-
Samueli Institute for Information BiologyWilliam Beaumont Army Medical CenterTerminated
-
Zekai Tahir Burak Women's Health Research and Education...UnknownAnemic Preterms, Cerebral Oxygenation,Somatic Oxygenation,Blood TransfusionTurkey
-
Universidad de ValparaisoComisión Nacional de Investigación Científica y TecnológicaUnknownOpen Angle GlaucomaChile
-
Taipei Medical University Shuang Ho HospitalActive, not recruiting